Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver
Evita van de Steeg, … , Milan Jirsa, Alfred H. Schinkel
Evita van de Steeg, … , Milan Jirsa, Alfred H. Schinkel
Published January 9, 2012
Citation Information: J Clin Invest. 2012;122(2):519-528. https://doi.org/10.1172/JCI59526.
View: Text | PDF
Research Article Hepatology Article has an altmetric score of 14

Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver

  • Text
  • PDF
Abstract

Bilirubin, a breakdown product of heme, is normally glucuronidated and excreted by the liver into bile. Failure of this system can lead to a buildup of conjugated bilirubin in the blood, resulting in jaundice. The mechanistic basis of bilirubin excretion and hyperbilirubinemia syndromes is largely understood, but that of Rotor syndrome, an autosomal recessive disorder characterized by conjugated hyperbilirubinemia, coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics, has remained enigmatic. Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3. These important detoxification-limiting proteins mediate uptake and clearance of countless drugs and drug conjugates across the sinusoidal hepatocyte membrane. OATP1B1 polymorphisms have previously been linked to drug hypersensitivities. Using mice deficient in Oatp1a/1b and in the multispecific sinusoidal export pump Abcc3, we found that Abcc3 secretes bilirubin conjugates into the blood, while Oatp1a/1b transporters mediate their hepatic reuptake. Transgenic expression of human OATP1B1 or OATP1B3 restored the function of this detoxification-enhancing liver-blood shuttle in Oatp1a/1b-deficient mice. Within liver lobules, this shuttle may allow flexible transfer of bilirubin conjugates (and probably also drug conjugates) formed in upstream hepatocytes to downstream hepatocytes, thereby preventing local saturation of further detoxification processes and hepatocyte toxic injury. Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia. Moreover, OATP1B1 and OATP1B3 null mutations may confer substantial drug toxicity risks.

Authors

Evita van de Steeg, Viktor Stránecký, Hana Hartmannová, Lenka Nosková, Martin Hřebíček, Els Wagenaar, Anita van Esch, Dirk R. de Waart, Ronald P.J. Oude Elferink, Kathryn E. Kenworthy, Eva Sticová, Mohammad al-Edreesi, A.S. Knisely, Stanislav Kmoch, Milan Jirsa, Alfred H. Schinkel

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2009 Total
Citations: 5 9 7 16 8 14 9 8 9 5 6 9 14 7 1 127
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (127)

Title and authors Publication Year
Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies
Chodup P, Samodelov SL, Visentin M, Kullak\u2010Ublick GA
Liver International 2025
A lipid metabolism related gene signature predicts postoperative recurrence in pancreatic cancer through multicenter cohort validation
Deng Z, Yang Z, Li L, Zeng G, Meng Z, Liu R
Scientific Reports 2025
The Impact of Organic Anion-Transporting Polypeptide (OATP) Variants on the Side Effects of Direct-Acting Antivirals in Hepatitis C Patients
Altintas Z, Altintas E
Cureus 2025
SLCO1B1 Functional Variants, Bilirubin, Statin-Induced Myotoxicity, and Recent Sub-Saharan African Ancestry: A Precision Medicine Health Equity Study.
Haldar T, Kvale M, Yang J, Douglas MP, Coyote-Maetas W, Kachuri L, Witte JS, Iribarren C, Medina MW, Krauss RM, Yee SW, Oni-Orisan A
Clinical pharmacology and therapeutics 2025
Bilirubin – new insights into an old molecule
Čepelak I, Dodig S, Pavić I
Biochemia Medica 2025
Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins.
Zhang Y, Huang J, Huang S, Liu J, Deng L, Liang C, Guo Y, Yao B, Wang X
Acta pharmaceutica Sinica. B 2024
Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice
Bechtold BJ, Lynch KD, Oyanna VO, Call MR, White LA, Graf TN, Oberlies NH, Clarke JD
Drug Metabolism and Disposition 2024
Rifampin- and Silymarin-mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model
Bechtold BJ, Lynch KD, Oyanna VO, Call MR, Graf TN, Oberlies NH, Clarke JD
Molecular Pharmaceutics 2024
A pedigree analysis of Rotor hyperbilirubinemia combined with hepatitis B virus infection in a SLCO1B1 and SLCO1B3 gene mutations patient.
Lin LZ, Wu QY, Zhang JH, Li SJ, Wu WZ, Ruan DD, Wu M, Chen Q, Liao LS, Fang ZT, Luo JW, Li ZA, Li Z, Li H
Heliyon 2024
STING-mediated IL-6 Inhibits OATP1B1 Expression via the TCF4 Signaling Pathway in Cholestasis.
Guo Y, Zhang H, Zhao N, Peng Y, Shen D, Chen Y, Zhang X, Tang CE, Chai J
Journal of Clinical and Translational Hepatology 2024
Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolism
Solé-Navais P, Juodakis J, Ytterberg K, Wu X, Bradfield JP, Vaudel M, LaBella AL, Helgeland Ø, Flatley C, Geller F, Finel M, Zhao M, Lazarus P, Hakonarson H, Magnus P, Andreassen OA, Njølstad PR, Grant SF, Feenstra B, Muglia LJ, Johansson S, Zhang G, Jacobsson B
Nature Communications 2024
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab.
Bellia M, Greco M, Lunghi M, Moia R, Gaidano G, Patriarca A
International medical case reports journal 2024
Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia
Sato T, Kawabata T, Kumondai M, Hayashi N, Komatsu H, Kikuchi Y, Onoguchi G, Sato Y, Nanatani K, Hiratsuka M, Maekawa M, Yamaguchi H, Abe T, Tomita H, Mano N
International Journal of Molecular Sciences 2024
SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report
Medwid S, Deckert R, Gryn SE, Kim RB
British Journal of Clinical Pharmacology 2024
Organic anion transporting polypeptide (OATP) 1B3 is a key transporter for hepatic uptake of conjugated bile acids in human liver
Qiong Pan, Jiafeng Ouyang, Ziqian Xu, Guanyu Zhu, Yao Tong, Nan Zhao, Xiaoxun Zhang, Ying Cheng, Liangjun Zhang, Ya Tan, Jianwei Li, Chengcheng Zhang, Wensheng Chen, Shi-Ying Cai, James Boyer, Jin Chai
Cellular and Molecular Gastroenterology and Hepatology 2023
Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies.
Vázquez-Meza H, Vilchis-Landeros MM, Vázquez-Carrada M, Uribe-Ramírez D, Matuz-Mares D
2023
Large-scale functional screen identifies genetic variants with splicing effects in modern and archaic humans
Rong S, Neil CR, Welch A, Duan C, Maguire S, Meremikwu IC, Meyerson M, Evans BJ, Fairbrother WG
Proceedings of the National Academy of Sciences 2023
Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis.
Xie S, Wei S, Ma X, Wang R, He T, Zhang Z, Yang J, Wang J, Chang L, Jing M, Li H, Zhou X, Zhao Y
Frontiers in pharmacology 2023
Role of the Sodium-Dependent Organic Anion Transporter (SOAT/SLC10A6) in Physiology and Pathophysiology
Wannowius M, Karakus E, Aktürk Z, Breuer J, Geyer J
International journal of molecular sciences 2023
Cryo-EM structures of human organic anion transporting polypeptide OATP1B1.
Shan Z, Yang X, Liu H, Yuan Y, Xiao Y, Nan J, Zhang W, Song W, Wang J, Wei F, Zhang Y
Cell Research 2023
Development of a Pharmacokinetic Model That Accounts for the Plasma Concentrations of Conjugated and Unconjugated Bilirubin Observed in a Variety of Disease States
Levitt DG, Levitt MD
Clinical and experimental gastroenterology 2023
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
E Järvinen, F Deng, W Kiander, A Sinokki, H Kidron, N Sjöstedt
Frontiers in pharmacology 2022
The individual and global impact of copy-number variants on complex human traits
C Auwerx, M Lepamets, M Sadler, M Patxot, M Stojanov, D Baud, R Mägi, E Porcu, A Reymond, Z Kutalik, T Esko, A Metspalu, L Milani, R Mägi, M Nelis
The American Journal of Human Genetics 2022
The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms
Cooper-DeHoff RM, Niemi M, Ramsey LB, Luzum JA, Tarkiainen EK, Straka RJ, Gong L, Tuteja S, Wilke RA, Wadelius M, Larson EA, Roden DM, Klein TE, Yee SW, Krauss RM, Turner RM, Palaniappan L, Gaedigk A, Giacomini KM, Caudle KE, Voora D
Clinical Pharmacology & Therapeutics 2022
Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population.
Atasilp C, Kanjanapipak J, Vichayaprasertkul J, Jinda P, Tiyasirichokchai R, Srisawasdi P, Prempunpong C, Chamnanphon M, Puangpetch A, Vanwong N, Klongthalay S, Jantararoungtong T, Sukasem C
BMC Pediatrics 2022
A study on setting standards for near-infrared fluorescence-image guided surgery (NIRFGS) time lapse monitoring based on preoperative liver function assessment.
Li Y, You Q, Wang Z, Cao Y, Butch CJ, Guissi NEI, Cai H, Wang Y, Lu Q
Annals of translational medicine 2022
Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A Bioinformatics Approach.
Da Costa GV, Neto MFA, Da Silva AKP, De Sá EMF, Cancela LCF, Vega JS, Lobato CM, Zuliani JP, Espejo-Román JM, Campos JM, Leite FHA, Santos CBR
International journal of molecular sciences 2022
Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake.
Hove VN, Anderson K, Hayden ER, Pasquariello KZ, Gibson AA, Shen S, Qu J, Jin Y, Miecznikowski JC, Hu S, Sprowl JA
Molecular pharmacology 2022
Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.
Talebi Z, Sparreboom A, Colace SI
Methods in molecular biology (Clifton, N.J.) 2022
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities
Li Y, Jin Y, Taheri H, Schmidt KT, Gibson AA, Buck SA, Eisenmann ED, Mathijssen RH, Figg WD, Baker SD, Sparreboom A, Hu S
Pharmaceutics 2022
Rotor Syndrome Presenting as Dubin-Johnson Syndrome.
Morais M, Couvert P, Jéru I, Machado MV
Case reports in gastroenterology 2022
iTRAQ Quantitative Proteomic Analysis of Different Expressed Proteins and Signal Pathways in Bakuchiol-Induced Hepatotoxicity
Gao SY, Xu DQ, Abulizi A, Maimaiti Y, Aibai S, Jiang ZZ, Zhang LY, Li ZJ
Evidence-based complementary and alternative medicine : eCAM 2022
Guarding the gate against hyperbilirubinaemia.
Zhang E, Huang W
Gut 2022
A historical review of jaundice: May the golden oriole live forever
Herta T, Beuers U
Clinical Liver Disease 2022
Identifying Novel Inhibitors for Hepatic Organic Anion Transporting Polypeptides by Machine Learning-Based Virtual Screening.
Tuerkova A, Bongers BJ, Norinder U, Ungvári O, Székely V, Tarnovskiy A, Szakács G, Özvegy-Laczka C, van Westen GJP, Zdrazil B
Journal of Chemical Information and Modeling 2022
Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review
Chunduri V, Maddi S
2022
PharmVar GeneFocus: SLCO1B1.
Ramsey LB, Gong L, Lee SB, Wagner JB, Zhou X, Sangkuhl K, Adams SM, Straka RJ, Empey PE, Boone EC, Klein TE, Niemi M, Gaedigk A
Clinical Pharmacology & Therapeutics 2022
Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
Y Li, Z Talebi, X Chen, A Sparreboom, S Hu
Molecules (Basel, Switzerland) 2021
Enzyme Kinetics in Drug Metabolism: Fundamentals and Applications
S Nagar, UA Argikar, D Tweedie
2021
Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates
S Medwid, HR Price, DP Taylor, J Mailloux, UI Schwarz, RB Kim, RG Tirona
Frontiers in pharmacology 2021
An EAV-HP insertion in the promoter region of SLCO1B3 has pleiotropic effects on chicken liver metabolism based on the transcriptome and proteome analysis
J Chen, G Hua, D Han, X Zheng, X Dong, S Wang, J Long, Z Zheng, A Wang, J Wang, X Wang, X Deng
Scientific Reports 2021
Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy
B Bechtold, J Clarke
Expert Opinion on Drug Metabolism & Toxicology 2021
Application of a PBPK model to elucidate the changes of systemic and liver exposures for rosuvastatin, carotegrast, and bromfenac followed by OATP inhibition in monkeys
Y Cheng, X Liang, J Hao, C Niu, Y Lai
Clinical and Translational Science 2021
CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics
Lu J, Liu J, Guo Y, Zhang Y, Xu Y, Wang X
Acta pharmaceutica Sinica. B 2021
The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges
Jeyaraj R, Bounford KM, Ruth N, Lloyd C, MacDonald F, Hendriksz CJ, Baumann U, Gissen P, Kelly D
Genes & development 2021
Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies
A Kriegermeier, R Green
Frontiers in Medicine 2020
OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation
Y Wang, RW Sparidans, W Li, MC Lebre, JH Beijnen, AH Schinkel
British Journal of Pharmacology 2020
Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease
X Ma, X Shang, X Qin, J Lu, M Liu, X Wang
Acta pharmaceutica Sinica. B 2020
Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
K Brecht, AM Schäfer, HE zu Schwabedissen
Cancers 2020
Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions
M Chen, S Hu, Y Li, AA Gibson, Q Fu, SD Baker, A Sparreboom
Drug Metabolism and Disposition 2020
Prediction of Drug-Induced Hyperbilirubinemia by In Vitro Testing
P Tátrai, P Krajcsi
Pharmaceutics 2020
Insertion of LINE-1 Retrotransposon Inducing Exon Inversion Causes a Rotor Syndrome Phenotype
D Zhou, S Qi, W Zhang, L Wu, A Xu, X Li, B Zhang, Y Li, S Jia, H Wang, J Jia, X Ou, J Huang, H You
Frontiers in Genetics 2020
Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study
HV Kalluri, R Kikuchi, S Coppola, J Schmidt, ME Mohamed, DA Bow, AH Salem
Clinical and Translational Science 2020
Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis
T Aiyama, T Orimo, H Yokoo, T Ohata, KC Hatanaka, Y Hatanaka, M Fukai, T Kamiyama, A Taketomi, JW Lee
PloS one 2020
Differences in the Hemolytic Behavior of Two Isomers in Ophiopogon japonicus In Vitro and In Vivo and Their Risk Warnings
HH Xu, ZH Jiang, YT Sun, LZ Qiu, LL Xu, XL Tang, ZC Ma, Y Gao, S Qin
Oxidative Medicine & Cellular Longevity 2020
Rotor Syndrome: Glucuronidated Bile Acidemia From Defective Reuptake by Hepatocytes
A Kimura, T Kagawa, H Takei, Y Maruo, H Sakugawa, T Sasaki, T Murai, N Naritaka, H Takikawa, H Nittono
Hepatology Communications 2020
The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions
Y Ali, T Shams, K Wang, Z Cheng, Y Li, W Shu, X Bao, L Zhu, M Murray, F Zhou
Chinese medicine 2020
Isolated Elevated Bilirubin
Shroff H, Maddur H
Clinical Liver Disease 2020
The first Turkish family with Rotor syndrome diagnosed at the molecular level
Gümüş E, Karaca M, Deveci U, Jirsa M
2020
Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology
RR Schulte, RH Ho
Molecular pharmacology 2019
Quantitative Kinetic Models from Intravital Microscopy: A Case Study Using Hepatic Transport
M Tavakoli, K Tsekouras, R Day, KW Dunn, S Pressé
The Journal of Physical Chemistry B 2019
Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma
A Hulin, J Stocco, M Bouattour
Clinical Pharmacokinetics 2019
Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice
Q Fu, M Chen, JT Anderson, X Sun, S Hu, A Sparreboom, SD Baker
Clinical and Translational Science 2019
Protein-protein interactions of drug uptake transporters that are important for liver and kidney
Y Zhang, B Hagenbuch
Biochemical Pharmacology 2019
Next generation sequencing reveals co-existence of hereditary spherocytosis and Dubin–Johnson syndrome in a Chinese gril: A case report
Y Li, Y Li, Y Yang, WR Yang, JP Li, GX Peng, L Song, HH Fan, L Ye, YZ Xiong, ZJ Wu, K Zhou, X Zhao, LP Jing, FK Zhang, L Zhang
World journal of clinical cases 2019
Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia
J Bai, L Luo, S Liu, C Liang, L Bai, Y Chen, S Zheng, Z Duan
Frontiers in Genetics 2019
The Emerging Role of the SLCO1B3 Protein in Cancer Resistance
R Sun, Y Ying, Z Tang, T Liu, F Shi, H Li, T Guo, S Huang, R Lai
Protein and peptide letters 2019
Influence of Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 and Solute Carrier Organic Anion Transporter Family 1 Member B1 Polymorphisms and Efavirenz on Bilirubin Disposition in Healthy Volunteers
KS Collins, IF Metzger, BT Gufford, JB Lu, EB Medeiros, VM Pratt, TC Skaar, Z Desta
Drug Metabolism and Disposition 2019
Animal models to study bile acid metabolism
J Li, PA Dawson
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018
Bilirubin in the Liver–Gut Signaling Axis
AR Hamoud, L Weaver, DE Stec, TD Hinds
Trends in endocrinology and metabolism: TEM 2018
Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions
K Alam, A Crowe, X Wang, P Zhang, K Ding, L Li, W Yue
International journal of molecular sciences 2018
Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1
I Patik, V Székely, O Német, Á Szepesi, N Kucsma, G Várady, G Szakács, É Bakos, C Özvegy-Laczka
Scientific Reports 2018
Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes
O Fardel, A Moreau, ML Vée, C Denizot, Y Parmentier
European Journal of Drug Metabolism and Pharmacokinetics 2018
Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases
HL Chen, SH Wu, SH Hsu, BY Liou, HL Chen, MH Chang
Journal of Biomedical Science 2018
Quantitative Prediction of OATP‐Mediated Drug‐Drug Interactions With Model‐Based Analysis of Endogenous Biomarker Kinetics
Yoshida K, Guo C, Sane R
The Journal of Pathology 2018
Variants Associated with Infantile Cholestatic Syndromes Detected in Extrahepatic Biliary Atresia by Whole Exome Studies: A 20-Case Series from Thailand
Sangkhathat S, Laochareonsuk W, Maneechay W, Kayasut K, Chiengkriwate P
Journal of pediatric genetics 2018
Bile Acid Uptake Transporters as Targets for Therapy
D Slijepcevic, SF van de Graaf
Digestive Diseases 2017
Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice
D Slijepcevic, RL Abbing, T Katafuchi, A Blank, JM Donkers, S Hoppe, DR de Waart, D Tolenaars, JH van der Meer, M Wildenberg, U Beuers, RP Elferink, AH Schinkel, SF van de Graaf
Hepatology 2017
Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review
J Čvorović, S Passamonti
Frontiers in pharmacology 2017
Glucuronidation: driving factors and their impact on glucuronide disposition
G Yang, S Ge, R Singh, S Basu, K Shatzer, M Zen, J Liu, Y Tu, C Zhang, J Wei, J Shi, L Zhu, Z Liu, Y Wang, S Gao, M Hu
Drug Metabolism Reviews 2017
2016 Presidential Address: Let’s Make Human Genetics Great (Again): The Importance of Beauty in Science 1
HC Dietz
The American Journal of Human Genetics 2017
Systems pharmacology modeling of drug-induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters
K Yang, C Battista, JL Woodhead, SH Stahl, JT Mettetal, PB Watkins, SQ Siler, BA Howell
Clinical Pharmacology & Therapeutics 2017
Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).
Lee HH, Ho RH
British Journal of Clinical Pharmacology 2017
eUnaG: a new ligand-inducible fluorescent reporter to detect drug transporter activity in live cells.
Yeh JT, Nam K, Yeh JT, Perrimon N
Scientific Reports 2017
Loss of organic anion transporting polypeptide 1B3 function causes marked delay in indocyanine green clearance without any clinical symptoms.
Kagawa T, Adachi Y, Hashimoto N, Mitsui H, Ohashi T, Yoneda M, Hasegawa I, Hirose S, Tsuruya K, Anzai K, Mine T
Hepatology 2017
ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes: de Waart, Naik et al
DR de Waart, J Naik, KS Utsunomiya, S Duijst, K Ho-Mok, AR Bolier, J Hiralall, LN Bull, PJ Bosma, RP Elferink, CC Paulusma
Hepatology 2016
Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury
K Yang, C Guo, JL Woodhead, RL st. Claire, PB Watkins, SQ Siler, BA Howell, KL Brouwer
Journal of Pharmaceutical Sciences 2016
Autosomal-Dominant Corneal Endothelial Dystrophies CHED1 and PPCD1 Are Allelic Disorders Caused by Non-coding Mutations in the Promoter of OVOL2
AE Davidson, P Liskova, CJ Evans, L Dudakova, L Nosková, N Pontikos, H Hartmannová, K Hodaňová, V Stránecký, Z Kozmík, HJ Levis, N Idigo, N Sasai, GJ Maher, J Bellingham, N Veli, ND Ebenezer, ME Cheetham, JT Daniels, CM Thaung, K Jirsova, V Plagnol, M Filipec, S Kmoch, SJ Tuft, AJ Hardcastle
The American Journal of Human Genetics 2016
Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver
MM Thomson, RN Hines, EG Schuetz, B Meibohm
Drug metabolism and disposition: the biological fate of chemicals 2016
Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter
S Imada, T Kobayashi, A Kitao, O Matsui, M Hashimoto, K Ide, K Ishiyama, K Arihiro, H Tashiro, H Ohdan
Surgical Case Reports 2016
Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b
A Vasilyeva, S Durmus, L Li, E Wagenaar, S Hu, AA Gibson, JC Panetta, S Mani, A Sparreboom, SD Baker, AH Schinkel
Cancer research 2015
SLC transporters as therapeutic targets: emerging opportunities
L Lin, SW Yee, RB Kim, KM Giacomini
Nature Reviews Drug Discovery 2015
Neonatal Cholestasis – Differential Diagnoses, Current Diagnostic Procedures, and Treatment
T Götze, H Blessing, C Grillhösl, P Gerner, Aà Hoerning
Frontiers in Pediatrics 2015
Genetic and biochemical study of dual hereditary jaundice: Dubin–Johnson and Gilbert’s syndromes. Haplotyping and founder effect of deletion in ABCC2
L Slachtova, O Seda, J Behunova, M Mistrik, P Martasek
European Journal of Human Genetics 2015
Structural and Functional Hepatocyte Polarity and Liver Disease
P Gissen, IM Arias
Journal of Hepatology 2015
Inherited disorders of bilirubin clearance
N Memon, BI Weinberger, T Hegyi, LM Aleksunes
Pediatric Research 2015
Gene Replacement Therapy for Genetic Hepatocellular Jaundice
R van Dijk, U Beuers, PJ Bosma
Clinical Reviews in Allergy & Immunology 2014
Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease
D Levitt, M Levitt
Clinical and experimental gastroenterology 2014
Comprehensive Physiology
AW Wolkoff
Comprehensive Physiology 2014
Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms
H Sato, T Uchida, K Toyota, T Nakamura, G Tamiya, M Kanno, T Hashimoto, M Watanabe, K Aoki, K Hayasaka
Journal of Human Genetics 2014
Development and Characterization of a Novel Mouse Line Humanized for the Intestinal Peptide Transporter PEPT1
Y Hu, Y Xie, Y Wang, X Chen, DE Smith
Molecular Pharmaceutics 2014
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, WD Maxwell, HL McLeod, RM Krauss, DM Roden, Q Feng, RM Cooper-DeHoff, L Gong, TE Klein, M Wadelius, M Niemi
Clinical Pharmacology & Therapeutics 2014
Substantial Effect of Efavirenz Monotherapy on Bilirubin Levels in Healthy Volunteers
IF Metzger, TC Quigg, N Epstein, AO Aregbe, N Thong, JT Callaghan, DA Flockhart, AT Nguyen, CK Stevens, SK Gupta, Z Desta
Current Therapeutic Research 2014
Not all (bile acids) who wander are lost: The first report of a patient with an isolated NTCP defect
SJ Karpen, PA Dawson
Hepatology 2014
Different Interaction Profiles of Direct-Acting Anti-Hepatitis C Virus Agents with Human Organic Anion Transporting Polypeptides
T Furihata, S Matsumoto, Z Fu, A Tsubota, Y Sun, S Matsumoto, K Kobayashi, K Chiba
Antimicrobial agents and chemotherapy 2014
Comprehensive Physiology
BJ Wilkins, M Pack
Comprehensive Physiology 2013
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
P Godoy, NJ Hewitt, U Albrecht, ME Andersen, N Ansari, S Bhattacharya, JG Bode, J Bolleyn, C Borner, J Böttger, A Braeuning, RA Budinsky, B Burkhardt, NR Cameron, G Camussi, CS Cho, YJ Choi, JC Rowlands, U Dahmen, G Damm, O Dirsch, MT Donato, J Dong, S Dooley, D Drasdo, R Eakins, KS Ferreira, V Fonsato, J Fraczek, R Gebhardt, A Gibson, M Glanemann, CE Goldring, MJ Gómez-Lechón, GM Groothuis, L Gustavsson, C Guyot, D Hallifax, S Hammad, A Hayward, D Häussinger, C Hellerbrand, P Hewitt, S Hoehme, HG Holzhütter, JB Houston, J Hrach, K Ito, H Jaeschke, V Keitel, JM Kelm, BK Park, C Kordes, GA Kullak-Ublick, EL LeCluyse, P Lu, J Luebke-Wheeler, A Lutz, DJ Maltman, M Matz-Soja, P McMullen, I Merfort, S Messner, C Meyer, J Mwinyi, DJ Naisbitt, AK Nussler, P Olinga, F Pampaloni, J Pi, L Pluta, SA Przyborski, A Ramachandran, V Rogiers, C Rowe, C Schelcher, K Schmich, M Schwarz, B Singh, EH Stelzer, B Stieger, R Stöber, Y Sugiyama, C Tetta, WE Thasler, T Vanhaecke, M Vinken, TS Weiss, A Widera, CG Woods, JJ Xu, KM Yarborough, JG Hengstler
Archives of Toxicology 2013
Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver
JL Staudinger, S Woody, M Sun, W Cui
Drug Metabolism Reviews 2013
Digenic inheritance in medical genetics
AA Schaffer
Journal of medical genetics 2013
New insights in bilirubin metabolism and their clinical implications
E Sticova, M Jirsa
World journal of gastroenterology : WJG 2013
Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide
EI Zimmerman, S Hu, JL Roberts, AA Gibson, SJ Orwick, L Li, A Sparreboom, SD Baker
Clinical cancer research 2013
Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics
AL Walker, CS Lancaster, D Finkelstein, RE Ware, A Sparreboom
American journal of physiology. Cell physiology 2013
Utility of Oatp1a/1b-Knockout and OATP1B1/3-Humanized Mice in the Study of OATP-Mediated Pharmacokinetics and Tissue Distribution: Case Studies with Pravastatin, Atorvastatin, Simvastatin, and Carboxydichlorofluorescein
JW Higgins, JQ Bao, AB Ke, JR Manro, JK Fallon, PC Smith, MJ Zamek-Gliszczynski
Drug Metabolism and Disposition 2013
Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
AT Nies, M Niemi, O Burk, S Winter, UM Zanger, B Stieger, M Schwab, E Schaeffeler
Genome Medicine 2013
ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans
MJ Zamek-Gliszczynski, CA Lee, A Poirier, J Bentz, X Chu, H Ellens, T Ishikawa, M Jamei, JC Kalvass, S Nagar, KS Pang, K Korzekwa, PW Swaan, ME Taub, P Zhao, A Galetin
Clinical Pharmacology & Therapeutics 2013
Mutations in ANTXR1 Cause GAPO Syndrome
V Stránecký, A Hoischen, H Hartmannová, MS Zaki, A Chaudhary, E Zudaire, L Nosková, V Barešová, A Přistoupilová, K Hodaňová, J Sovová, H Hůlková, L Piherová, JY Hehir-Kwa, D de Silva, MP Senanayake, S Farrag, J Zeman, P Martásek, A Baxová, HH Afifi, B St. Croix, HG Brunner, S Temtamy, S Kmoch
The American Journal of Human Genetics 2013
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation
F Bonifazi, G Storci, G Bandini, E Marasco, E Dan, E Zani, F Albani, S Bertoni, A Bontadini, SD Carolis, MR Sapienza, S Rizzi, MR Motta, M Ferioli, P Garagnani, M Cavo, V Mantovani, M Bonafe
2013
Uptake Carriers and Oncology Drug Safety
JA Sprowl, A Sparreboom
Drug metabolism and disposition: the biological fate of chemicals 2013
Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines.
Imai S, Kikuchi R, Tsuruya Y, Naoi S, Nishida S, Kusuhara H, Sugiyama Y
Pharmaceutical Research 2013
Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel
AJ de Graan, CS Lancaster, A Obaidat, B Hagenbuch, L Elens, LE Friberg, P de Bruijn, S Hu, AA Gibson, GH Bruun, TJ Corydon, TS Mikkelsen, AL Walker, G Du, WJ Loos, RH van Schaik, SD Baker, RH Mathijssen, A Sparreboom
Clinical cancer research 2012
The SLCO (former SLC21) superfamily of transporters
B Hagenbuch, B Stieger
Molecular Aspects of Medicine 2012
OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition
CS Lancaster, GH Bruun, CJ Peer, TS Mikkelsen, TJ Corydon, AA Gibson, S Hu, SJ Orwick, RH Mathijssen, WD Figg, SD Baker, A Sparreboom
Clinical Pharmacology & Therapeutics 2012
Loss of OATP1B3 function causes Rotor syndrome: Implications for potential use of inhibitors in cancer
E Pratt, TM Sissung, WD Figg
Cancer biology & therapy 2012
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, Krauss RM, Roden DM, Feng Q, Cooper-Dehoff RM, Gong L, Klein TE, Wadelius M, Niemi M
Clinical Pharmacology & Therapeutics 2012
Contribution of the OATP1B subfamily to cancer biology and treatment.
Sissung TM, Reece KM, Spencer S, Figg WD
Clinical Pharmacology & Therapeutics 2012
Current challenges and controversies in drug-induced liver injury.
Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M
Drug Safety 2012
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 5 patents
On 1 Facebook pages
Referenced in 5 Wikipedia pages
Highlighted by 1 platforms
Referenced in 1 clinical guideline sources
193 readers on Mendeley
See more details